Logo image of CORV.CA

Correvio Pharma Corp (CORV.CA) Stock Price, Forecast & Analysis

Canada - TSX:CORV -

0.56
0 (0%)
Last: 5/29/2020, 3:31:13 PM

CORV.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap37.07M
Revenue(TTM)32.63M
Net Income(TTM)-35184000
Shares66.19M
FloatN/A
52 Week High3.66
52 Week Low0.36
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.79
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


CORV.CA short term performance overview.The bars show the price performance of CORV.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

CORV.CA long term performance overview.The bars show the price performance of CORV.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of CORV.CA is 0.56 null. In the past month the price increased by 1.82%. In the past year, price decreased by -81.33%.

Correvio Pharma Corp / CORV Daily stock chart

CORV.CA Latest News, Press Relases and Analysis

5 years ago - By: Correvio Pharma Corp - Mentions: CORV
News Image
5 years ago - By: Correvio Pharma Corp - Mentions: CORV
News Image
6 years ago - By: Correvio Pharma Corp - Mentions: CORV
News Image
6 years ago - By: Correvio Pharma Corp - Mentions: CORV
News Image
6 years ago - By: Correvio Pharma Corp - Mentions: CORV
News Image
6 years ago - By: Correvio Pharma Corp - Mentions: CORV
News Image
6 years ago - By: Correvio Pharma Corp - Mentions: CORV
News Image
6 years ago - By: Correvio Pharma Corp - Mentions: CORV
News Image

About CORV.CA

Company Profile

Correvio Pharma Corp, formerly Cardiome Pharma Corp is a specialty pharmaceutical company. It is engaged in the development and commercialization of cardiovascular therapies. The company's products include AGGRASTAT, EXEMBOL, BRINAVESS and others.

Company Info

Correvio Pharma Corp

1441 Creekside Drive

Vancouver BC V6J 4S7

CEO: William L. Hunter

Phone: +1 604 677-6905

Correvio Pharma Corp / CORV.CA FAQ

Can you describe the business of Correvio Pharma Corp?

Correvio Pharma Corp, formerly Cardiome Pharma Corp is a specialty pharmaceutical company. It is engaged in the development and commercialization of cardiovascular therapies. The company's products include AGGRASTAT, EXEMBOL, BRINAVESS and others.


What is the stock price of Correvio Pharma Corp today?

The current stock price of CORV.CA is 0.56 null.


Does Correvio Pharma Corp pay dividends?

CORV.CA does not pay a dividend.


What is the ChartMill rating of Correvio Pharma Corp stock?

CORV.CA has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


CORV.CA Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to CORV.CA. When comparing the yearly performance of all stocks, CORV.CA is a bad performer in the overall market: 92.21% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CORV.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to CORV.CA. Both the profitability and financial health of CORV.CA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CORV.CA Financial Highlights

Over the last trailing twelve months CORV.CA reported a non-GAAP Earnings per Share(EPS) of -0.79. The EPS decreased by -68.09% compared to the year before.


Industry RankSector Rank
PM (TTM) -107.81%
ROA -59.74%
ROE N/A
Debt/Equity -32.66
Chartmill High Growth Momentum
EPS Q2Q%61.11%
Sales Q2Q%26.59%
EPS 1Y (TTM)-68.09%
Revenue 1Y (TTM)13.81%

CORV.CA Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y-10.13%
Revenue Next YearN/A

CORV.CA Ownership

Ownership
Inst Owners5.18%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A